Strive Reports Preliminary Q4 Financials, $67.6M Cash & 7,626.8 Bitcoin Holdings, Citing Merger Dilution

summarizeSummary

Strive, Inc. reported preliminary Q4 2025 financials, including $67.6 million in cash and 7,626.8 Bitcoin, acquired through ongoing stock and warrant issuances, and highlighted potential dilution from its proposed merger with Semler Scientific.

check_boxKey Events

• Preliminary Q4 2025 Financials

  Strive, Inc. reported preliminary unaudited financials as of December 31, 2025, including $67.6 million in cash and cash equivalents.

• Significant Bitcoin Holdings

  The company held 7,626.8 Bitcoin as of year-end 2025, acquired at an average cost of $113,153 per bitcoin, representing a substantial asset base.

• Continued Bitcoin Acquisition

  During Q4 2025, Strive acquired an additional 1,741.2 Bitcoin at an average cost of $103,346, funded by warrant exercises and issuances of Class A common stock and preferred stock.

• Merger-Related Dilution Noted

  The filing explicitly noted dilution caused by the issuance of Class A common stock in connection with the proposed merger with Semler Scientific, for which an S-4 registration statement was previously filed.

auto_awesomeAnalysis

This 8-K provides a crucial, albeit preliminary, update on Strive's financial position and its ongoing capital strategy. The disclosure of substantial Bitcoin holdings, valued at over $860 million at average cost, underscores the company's significant exposure to the cryptocurrency market. The continued acquisition of Bitcoin, financed through stock and warrant issuances, indicates an aggressive capital deployment strategy that is inherently dilutive to existing shareholders. Furthermore, the explicit mention of dilution related to the proposed merger with Semler Scientific highlights a key risk factor for investors. While the financial figures are unaudited, their magnitude and the context of a major merger make this a very important filing for understanding the company's asset base, financing activities, and future capital structure. Investors should monitor the final audited financials and further details on the Semler Scientific merger.